ANDA 85873, held by Alpharma US Pharms. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85873 (Butabarb), held by Alpharma US Pharms, was first approved by FDA on May 17, 1978, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarb30MG/5ML ยท elixir;oral | Butabarbital Sodium | Discontinued |
| Apr 29, 1991 | Supplement 54Labeling | Approved | None posted |
| May 7, 1990 | Supplement 49Labeling | Approved | None posted |
| Jan 22, 1990 | Supplement 48Labeling | Approved | None posted |
| Feb 8, 1989 | Supplement 41Labeling | Approved | None posted |
| Nov 22, 1988 | Supplement 42Labeling | Approved | None posted |
| Nov 22, 1988 | Supplement 43Labeling | Approved | None posted |
| May 17, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters